HilleVax Current Cash

The latest current cash for HLVX is $59M as of June 2025. That compares with $110M in the prior-year period — down 45.9% year over year. Investors often review this figure alongside HilleVax's historical trend and sector peers before judging valuation or financial health.

Over the past year, HLVX's current cash moved from $110M to $59M — a 45.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in HilleVax's operating scale or balance-sheet position.

A current cash figure of $59M for HLVX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting HLVX's current cash ($59M), review year-over-year change from $110M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.